For more than 20 years, myo-Ins have been considered a safe and effective therapy, especially for the management of Polycystic Ovary Syndrome (PCOS), an endocrine-metabolic disorder characterized by altered insulin signaling [5]. The gene discussed is INS; the disease is polycystic ovary syndrome.